3628 results for «2225»

Filter By

3628 results

Mitral TEER - Part 1

19 Nov 2023 – From PCR London Valves 2023

Consult this session to gain insights into the complexities of Mitral TEER: witness an innovative solution for recurrent mitral regurgitation post-M-TEER showcasing the efficacy of three MitraClips, navigate the challenging terrain of mitral flail repair in a patient with a left main chronic total occlusion, explore...

Mitral TEER - Part 1

Complications of mitral valve interventions

19 Nov 2023 – From PCR London Valves 2023

Learn more about the complexities of mitral valve interventions with this selection of cases: witness the challenges posed by clip embolisation during Mitral TEER, delve into the scenario of SAM following TMVI leading to left ventricular outflow tract obstruction, explore the closure of an iatrogenic ASD...

Complications of mitral valve interventions

Mitral Late-Breaking Trials: CLASP IID, AltaValve transseptal programme, MitraSwiss in men and women, MiCLASP...

19 Nov 2023 – From PCR London Valves 2023

Discover the mitral late-breaking trials which were presented during PCR London Valves 2023: 

  • One-year outcomes of transcatheter mitral repair from the CLASP IID Registry
  • AltaValve transseptal programme update
  • Mitral TEER in men and women from MitraSwiss registry: is equality achieved?
  • Combined impact of mitral valve gradients and mitral regurgitation reduction...
Mitral Late-Breaking Trials - PCR London Valves 2023

Tricuspid TEER - Part 1

19 Nov 2023 – From PCR London Valves 2023

Gain insights into Tricuspid Transcatheter Edge-to-Edge Repair (TEER) with this session: explore the congestion patterns observed in severe tricuspid regurgitation and gain a deeper understanding of transcatheter treatment modalities, delve into the baseline characteristics of the Tri.Fr randomized trial on treating tricuspid regurgitation, witness the application...

Tricuspid TEER - Part 1

Tricuspid Late-Breaking Trials: TRISCEND at 2 years, TEER in primary tricuspid regurgitation, TriCLASP, bRIGHT...

19 Nov 2023 – From PCR London Valves 2023

Discover the tricuspid late-breaking trials which were presented during PCR London Valves 2023: 

  • TRISCEND study two-year outcomes: transfemoral TTVR
  • Transcatheter edge-to-edge repair in patients with primary tricuspid regurgitation
  • One-year outcomes of transcatheter tricuspid valve repair from the TriCLASP study
  • TTVR with the LuX-Valve system: one-year outcomes of a multicentre experience
  • Real-world...
Tricuspid Late-Breaking Trials

TAVI in cardiogenic shock

19 Nov 2023 – From PCR London Valves 2023

Because TAVI implantation, a routine procedure, is not always a breeze, look at a number of challenging cases, including a case of aortic stenosis complicated by cardiogenic shock, an emergency valve-in-valve TAVI, or a TAVI for left ventricular assist device.

TAVI in cardiogenic shock

Tricuspid valve interventions - Case studies

19 Nov 2023 – From PCR London Valves 2023

Explore a diverse range of tricuspid valve interventions through various case studies such as the multimodality percutaneous treatment of severe tricuspid regurgitation, Triclip subacute single leaflet detachment, bicaval valve implantation and more.

TAVI in complex scenarios

19 Nov 2023 – From PCR London Valves 2023

What do we mean by "complex scenarios"? When zero-contrast TAVI implantation becomes a good alternative in kidney disease, when TAVI is implanted in a patient with mechanical mitral valve, or when TAVI is implanted in very large annulus with subannular aneurysm, for example!

TAVI in complex scenarios

Late-breaking trials on latest-generation aortic valves and dedicated transcatheter devices

20 Nov 2023 – From PCR London Valves 2023

Find out the outcomes of the main studies on the latest-generation valves and devices presented at PCR LV 2023 to better determine their benefits, performance and interest in the treatment of specific aortic pathologies: REACCESS-2 Study, ACURATE Neo2 PMCF post-market registry, OCEAN-TAVI registry, ShortCut Pivotal Study, and...

Late-breaking trials on latest-generation aortic valves and dedicated transcatheter devices

TAVI - Patient selection

20 Nov 2023 – From PCR London Valves 2023

Gain essential insights into TAVI patient selection through these selected abstract submissions from PCR London Valves 2023: explore the benefits of guideline-directed therapy for severe aortic stenosis, unravel the significance of subthreshold aortic valve calcium scores in patients with cardiac amyloidosis and aortic stenosis, delve into...

TAVI - Patient selection

TAVI in challenging aortic anatomy

20 Nov 2023 – From PCR London Valves 2023

Explore TAVI in challenging aortic anatomy through this selection of cases: navigate strategies for crossing severely adverse calcific bicuspid aortic valves in horizontal aortas, witness TAVI adaptability in cases of severe aortic stenosis with situs inversus totalis, learn about the complexities of TAVI implantation in patients...

TAVI in challenging aortic anatomy

TAVI - New indications, techniques and devices - Part 2

20 Nov 2023 – From PCR London Valves 2023

Consult this session for a swift overview of evolving TAVI indications and techniques: gain insights into thirty-day outcomes with Evolut FX, stratified by heart team risk, witness the 12-month follow-up of the Valvosoft first-in-man study, uncover sizing considerations in bicuspid tapered aortic valves undergoing TAVI from the...

TAVI - New indications, techniques and devices - Part 2

Tricuspid TEER - Part 2

20 Nov 2023 – From PCR London Valves 2023

Advanced imaging strategies in transcatheter tricuspid valve therapies

03 Feb 2024 – From PCR Imaging Valves Madrid 2024

In this PCR Imaging Valves Madrid 2024 session, discover the use of various imaging techniques in transcatheter tricuspid valve therapies, ranging from standard TEE screening to comprehensive intra-procedural assessments, facilitating optimal device selection, procedural success, and post-procedural monitoring.

Advanced imaging strategies in transcatheter tricuspid valve therapies

Rapid-fire - Complications of Mitral TEER - Part 1

17 Feb 2024 – From PCR Tokyo Valves 2024

Gain valuable insights into the possible complications of Mitral Transcatheter Edge-to-Edge Repair (TEER) in the first part of this session rapid-fire submission cases. Learn about what might cause a loud rumbling sound after intervention, and explore a rare complication of the MitraClip procedure. 

Rapid-fire - Complex procedure in TAVI - Part 1

17 Feb 2024 – From PCR Tokyo Valves 2024

In the first part of this rapid-fire session, we focus on complex cases that might arise during TAVI, such as how to navigate a permanent pacemaker implantation, TAVI in a post-liver transplant patient with severe aortic regurgitation, or complex TAVI by transcarotid access.

TAVI and future coronary access - LIVE case

18 Feb 2024 – From PCR Tokyo Valves 2024

An 81-year-old woman, with a history of breast cancer surgery, stroke, and lymphoma remission, presented a severe symptomatic aortic stenosis associated with a suspicion of right coronary artery disease on the CT. The operators decided to perform TAVI first and then control the RCA by angiography...

TAVI and future coronary access - LIVE case

Late-Breaking Trial session

17 Feb 2024 – From PCR Tokyo Valves 2024

Explore pivotal findings from registries and studies, including the OCEAN-TAVI Registry on PPM prevalence in Asian TAVR patients, SIL-TAVI Registry insights on TAVI outcomes in cancer patients, the EXPAND G4 study's outcomes for Japanese MitraClip G4 recipients, and TRISTAR study's 30-day results on K-Clip for tricuspid...

Late-Breaking Trial session

Heart Team in action: managing complex cases together

17 Feb 2024 – From PCR Tokyo Valves 2024

In this group discussion, several heart teams present their work on complex cases of tricuspid valve interventions and explore the results of their collaboration in order to figure out adequate management for invasive treatments. 

Plan your moves: strategies for valves re-intervention

17 Feb 2024 – From PCR Tokyo Valves 2024

This special session sponsored by Edwards Lifesciences focuses on recognising key elements of valve design that impact ability to host future valves re-interventions, learning how to achieve repeatable implant experiences for the index valve and second valve, and identifying strategies to simplify transcatheter heart valve redo...

Didn’t find what you were looking for?